Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-20-022272
Filing Date
2020-08-14
Accepted
2020-08-14 16:21:21
Documents
9
Effectiveness Date
2020-08-14

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea125539-s8_aditxtherap.htm S-8 54921
2 ADITX THERAPEUTICS, INC. 2017 EQUITY INCENTIVE PLAN ea125539ex4-1_aditxtherap.htm EX-4.1 170057
3 OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP ea125539ex5-1_aditxtherap.htm EX-5.1 11097
4 CONSENT OF DBBMCKENNON INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea125539ex23-1_aditxtherap.htm EX-23.1 1402
5 GRAPHIC image_001.jpg GRAPHIC 3475
6 GRAPHIC image_002.jpg GRAPHIC 18152
7 GRAPHIC image_003.jpg GRAPHIC 8671
8 GRAPHIC ex10-6_001.jpg GRAPHIC 10912
9 GRAPHIC ex10-6_002.jpg GRAPHIC 8400
  Complete submission text file 0001213900-20-022272.txt   307536
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-246324 | Film No.: 201105403
SIC: 2834 Pharmaceutical Preparations